Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis-Reference-Cited by-同舟云学术

Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis

Published:2020-05-25 Issue:6 Volume:7 Page:945-955
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Rosso Mattia¹²,Gonzalez Cindy T.¹²,Healy Brian C.¹²³,Saxena Shrishti¹²,Paul Anu¹²,Bjornevik Kjetil⁴^ORCID,Kuhle Jens⁵^ORCID,Benkert Pascal⁶,Leppert David⁵,Guttmann Charles¹²,Bakshi Rohit¹²⁷^ORCID,Weiner Howard L.¹²⁷,Chitnis Tanuja¹²⁷^ORCID

Affiliation:

1. Harvard Medical School Boston Massachusetts 02115 USA

2. Ann Romney Center for Neurologic Disease Harvard Medical School Boston Massachusetts 02115 USA

3. Massachusetts General Hospital Biostatistics Center Boston Massachusetts USA

4. Department on Nutrition Harvard T.H. Chan School of Public Health Boston Massachusetts USA

5. Departments of Medicine, Biomedicine and Clinical Research Neurologic Clinic and Policlinic University Hospital Basel University of Basel Basel Switzerland

6. Department of Clinical Research Clinical Trial Unit University Hospital Basel University of Basel Basel Switzerland

7. Department of Neurology Partners Multiple Sclerosis Center Brigham and Women's Hospital Boston Massachusetts USA

Funder

EMD Serono

U.S. Department of Defense

Nancy Davis Foundation for Multiple Sclerosis

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51060

Reference36 articles.

1. Natural history of multiple sclerosis: a unifying concept

2. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

3. Redefining acute relapses in multiple sclerosis: implications for phase 3 clinical trials and treatment algorithms;Avasarala J;Innov Clin Neurosci,2017

4. Time-series modeling of multiple sclerosis disease activity: A promising window on disease progression and repair potential?

5. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis;Annals of Clinical and Translational Neurology;2024-09-05

2. Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment;Multiple Sclerosis and Related Disorders;2024-08

3. Glial fibrillary acidic protein and neurofilament light chain as biomarkers in pediatric multiple sclerosis;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2024-07

4. Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis;Journal of Personalized Medicine;2024-06-27

5. Association of Dietary Retinol Intake and Serum Neurofilament Light Chain Levels: Results from NHANES 2013–2014;Nutrients;2024-06-04